Stock·NYSE·Energy
SLB N.V. (SLB)
- Market cap
- $73.47B
- P/E
- 23.43
- Dividend yield
- 2.36%
- Street target
- $63.00median of 30 analysts
- 52-week range
- $32.50 $60.46
The short version
Where SLB stands today, in four lines, and what CleaRank Financial AI makes of it.
SLB at a glance
SLB N.V. (SLB): Hold, 46/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($52.66 and $51.03).
- Earnings SLB beat estimates in 4 of its last 5 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $27.2M and made no open-market purchases over the last 18 months.
- Valuation P/E of 23.4 against 18.4 for the Energy sector: a premium to peers (+27%).
Figures as of October 16, 2026.
CleaRank Financial AI
SLB N.V. (SLB) carries a CleaRank rating of Hold and a model score of 46/100.
Analysts lift the score the most: 26 of 30 rate the stock a buy, and the median target is 27.3% above the price. Revenue growth pulls the score down the most, with revenue up 5.00%, 27.8 percentage points slower than the sector median. The trend points down, as SLB trades 6.00% below its 50-day average of $52.66 and 3.01% below its 200-day average of $51.03. Still, the price rose 50.36% over the past year.
Only on CleaRank
Figures we compute ourselves from SLB's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
2/4Price above its 50-day average ›
The price of $49.50 is 6.0% below the 50-day simple moving average of $52.66.Price above its 200-day average ›
The price is 3.0% below the 200-day simple moving average of $51.03.50-day average above the 200-day ›
The 50-day average ($52.66) is 3.2% above the 200-day average ($51.03), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 61% of its 52-week range, between $32.50 and $60.46.
SLB share price
Pick a period: each tab shows how far SLB has moved over it, to the last close.
Today's trading
Where SLB sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 23.43 is 27.4% above the Energy median of 18.4.P/S below the sector median ›
The price-to-sales ratio of 1.98 is 20.8% below the sector median of 2.5.Profitable over the last 12 months ›
Net income over the last 12 months was $3.1B on revenue of $36.4B, a net margin of 8.5%.Beat estimates in most recent reports ›
SLB beat the EPS estimate in 4 of its last 5 reports.Pays a dividend ›
The trailing dividend yield is 2.36%, or $1.17 a share a year.
Key statistics
The headline figures for SLB.
As of October 16, 2026, SLB trades at $49.50, with a market value of $73.47B, a P/E ratio of 23.43 and a dividend yield of 2.36%.
What the numbers say
CleaRank Financial AI's reading of SLB's valuation, growth and risks.
SLB N.V. (SLB) trades at 23.43 times earnings, versus a sector median of 18.4 for Energy. That leaves the P/E 27.4% above the median, which makes it a premium to peers. On sales, the P/S of 1.98 is 20.8% below the sector median of 2.5. For scale, the company has a market value of $73.5B and trailing earnings of $2.07 per share.
Revenue grew 5.00% in the latest year, which is 27.8 percentage points slower than the sector median of 32.8%. On profitability, the net margin is 8.53% and the operating margin is 12.71%. Return on equity comes in at 12.91%, below the sector median of 14.2%. The balance sheet carries a debt-to-equity ratio of 0.47, and the trailing dividend yield of 2.36% works out to $1.17 a share each year.
SLB's July 24, 2026 report topped expectations by 5.77%, with EPS of $0.55 against the $0.52 analysts had forecast. Even so, the share price moved the other way, falling 1.70% in the next session.
SLB beat the EPS estimate in 4 of its last 5 reports, but beats have not guaranteed gains: the stock fell the next day after 1 of them. Analysts' average EPS estimate for this fiscal year is $2.48, which would be a decline of 15.3%, and $3.21 for next year (growth of 29.5%).
A P/E of 23.43 sits 27.4% above the sector median, a premium to peers on the Peer Benchmarking card, so there is less room for disappointment. SLB's price typically shifts by 1.81% on a given day, based on the 30-day standard deviation of its daily returns. While the price stays under both moving averages, the downtrend remains a risk. The price is 18.13% below the 52-week high of $60.46.
SLB against the Energy sector
How SLB compares with the median Energy stock CleaRank tracks.
Price to earnings vs sector: SLB trades at a significant premium to sector peers (+27%), suggesting market expectations for superior growth or market position.
Return vs XLE: Since May 6, 2025, SLB has gained 47.4% against a gain of 68.9% for XLE.
Performance against XLE
SLB and the Energy sector fund over the same days.
Revenue and earnings
How much SLB sells, and how much of it becomes profit.
Revenue growth: Revenue fell 1.6% in FY2025 to $35.7B, from $36.3B a year earlier.
Profit margin: The net margin was 9.7% in FY2025, down from 12.6% the year before.
Profitable: SLB earned $3.5B in FY2025.
Earnings reality check
Did SLB beat what analysts expected, and how did the stock react?
Earnings record: SLB beat the analyst estimate in 4 of the last 5 quarters.
Market reaction: The stock fell in the first session after 1 of those 4 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 24, 2026after close | $0.52 | $0.55 | +5.77% | -1.70% | -5.40% |
| Jan 23, 2026after close | $0.74 | $0.78 | +5.41% | +1.12% | -1.57% |
| Jul 18, 2025after close | $0.73 | $0.74 | +1.37% | +0.66% | +6.45% |
| Apr 25, 2025after close | $0.73 | $0.72 | -1.37% | -1.22% | +0.61% |
| Jan 17, 2025after close | $0.90 | $0.92 | +2.22% | +0.37% | -2.39% |
As of October 16, 2026, SLB has beaten the analyst EPS estimate in 4 of its last 5 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on July 24, 2026, came in 5.77% above the estimate and the stock moved -1.70% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 44.4, in neutral territory.RSI above 50 ›
An RSI of 44.4 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of SLB
The score, the reasoning behind it, and what could move the price next.
SLB N.V. (SLB) sits in a downtrend: both averages lie above the price. At $49.50, the stock is 6.00% below its 50-day average of $52.66 and 3.01% below its 200-day average of $51.03. The 50-day average is 3.18% above the 200-day average. Across its 52-week range, running from $31.64 to $60.46, the price currently stands at 62% of the way up.
A recent pullback sits inside a stronger longer record: the price fell 5.35% over the past month, rose 5.34% over the past three months and rose 50.36% over the past year. The price rose 2.34% in the last session on volume 66.2% above its average. On momentum, the 14-day RSI reads 44.4, in the neutral zone, with the MACD line negative.
Earnings beat ›
The July 24, 2026 report beat the EPS estimate by 5.77%, and the share price fell 1.70% in the first session after it.
Source: Earnings report, July 24, 2026
Rating reaffirmed ›
UBS kept its Buy rating on September 14, 2026.
Source: Analyst action, UBS, September 14, 2026
- The two closest levels matter most: the 20-day EMA at $49.97 sits above the price, and the 52-week low at $31.64 sits below it.
- The 14-day RSI is 44.4, in the neutral zone, and the MACD line is negative. Readings above 70 or below 30 would signal stretched momentum.
- Following the July 24, 2026 report, the share price fell 1.70% in the first session. Over the last 5 reports, SLB beat estimates in 4.
The downtrend stays in place while SLB is below both its 50-day average at $52.66 and its 200-day average at $51.03; a close back above the 200-day would be the first step of a repair. The 20-day EMA at $49.97 is the first hurdle overhead.
The next level below the price is the 52-week low of $31.64. The 14-day RSI reads 44.4, which places SLB in neutral territory between 40 and 60.
Technical indicators
Momentum and trend for SLB, from its daily closes.
As of October 16, 2026, with SLB at $49.50, its 14-day RSI is 44.4 (neutral territory), its 50-day simple moving average is $52.66 and its 200-day is $51.03.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What SLB moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, SLB's 1-year correlation of daily returns is +0.46 with S&P 500 (SPY), +0.36 with Nasdaq 100 (QQQ), +0.10 with Bitcoin (BTC) and +0.15 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
26 of 30 analysts rate it a buy or strong buy, 2 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $63.00 is 27.3% above the price.More buy ratings than three months ago ›
26 of 30 rate it a buy now, against 26 of 30 three months ago.
SLB Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 14, 2026 | UBS | Maintains | Buy |
| Sep 9, 2026 | UBS | Maintains | Buy |
| Jul 27, 2026 | Piper Sandler | Maintains | Overweight |
| Jul 27, 2026 | TD Cowen | Maintains | Buy |
| Jul 27, 2026 | Morgan Stanley | Maintains | Overweight |
| Jul 27, 2026 | Evercore ISI Group | Maintains | Outperform |
As of October 16, 2026, 30 Wall Street analysts cover SLB: 26 rate it a buy or strong buy, 2 a hold and 2 a sell or strong sell. Their 12-month price targets range from $43.00 to $75.00, with a median of $63.00, 27.3% above the price of $49.50.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
SLB trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from SLB's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much SLB tends to move, against the market and on its own.
The long record
SLB's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
1/4Average daily move under 2% ›
The price has moved 1.81% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 81.7%, from January 2017 to March 2020; the price is still 24.8% below that peak.Most 1-year holds ended higher ›
48% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $7,890.14, against $42,525 in the S&P 500 (SPY).
SLB Drawdowns & Recovery
As of October 16, 2026, SLB's worst peak-to-trough fall over the last 10 years with dividends reinvested was -81.7% (January 2017 to March 2020); it is still 24.8% below that peak, and 48% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into SLB in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: SLB trailed the S&P 500 over this period: $7,890.14 against $42,525.
A $10,000 investment in SLB in October 2016 would be worth about $7,890 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to SLB, and which have not.
Strongest month, January: an average of +11.32%, up in 7 of 10 years.
Weakest month, March: an average of -5.37%, up in 3 of 10 years.
This month, October: has averaged +2.86%, up in 3 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, SLB's strongest calendar month has been January (average +11.32%, up in 7 of 10 years) and its weakest March (average -5.37%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in SLB, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in SLB today could grow to about $10,180 by 2036 in the base case, with a 90th-percentile outcome near $53,996 and a 10th-percentile outcome around $1,919. The simulation models price only; at today's 2.36% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
SLB Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $49.85 for SLB by 2030 in the base case, from $49.50 today (1.0x over 4 years). The 10th-percentile path ends near $17.35. These are outcomes of a Monte Carlo simulation run on SLB's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $29.26 | $49.59 | $84.05 | |
| 2028 | $23.56 | $49.68 | $105 | |
| 2029 | $19.95 | $49.77 | $124 | |
| 2030 | $17.35 | $49.85 | $143 | |
| 2031 | $15.35 | $49.94 | $163 |
Method: a lognormal simulation of SLB's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
SLB insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought SLB shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 16, 2026, SLB insiders reported 22 open-market sales worth $27.2M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 1, 2026 | Peuch Olivier Le
Chief Executive Officer
|
Sell | 35.0K | $2.1M |
| Aug 31, 2026 | Peuch Olivier Le
Chief Executive Officer
|
Sell | 5.0K | $300.0K |
| Aug 27, 2026 | Peuch Olivier Le
Chief Executive Officer
|
Sell | 5.0K | $275.0K |
| Aug 26, 2026 | Peuch Olivier Le
Chief Executive Officer
|
Sell | 25.0K | $1.3M |
| May 27, 2026 | Peuch Olivier Le
Chief Executive Officer
|
Sell | 25.0K | $1.4M |
| May 7, 2026 | La Chevardiere Patrick De
Director
|
Sell | 2.0K | $108.7K |
| May 1, 2026 | Steve Matthew Gassen
Officer
|
Sell | 53.4K | $3.0M |
| May 1, 2026 | Peter John Coleman
Director
|
Grant | 3.4K | - |
| May 1, 2026 | La Chevardiere Patrick De
Director
|
Grant | 3.4K | - |
| May 1, 2026 | Miguel Matias Galuccio
Director
|
Grant | 3.4K | - |
| May 1, 2026 | Steve Matthew Gassen
Officer
|
Option | 33.4K | $1.3M |
| May 1, 2026 | James T Hackett
Director
|
Grant | 5.5K | - |
| May 1, 2026 | Samuel Georg Friedrich Leupold
Director
|
Grant | 3.4K | - |
| May 1, 2026 | Hanssen Maria Moraeus
Director
|
Grant | 3.4K | - |
| May 1, 2026 | Vanitha Narayanan
Director
|
Grant | 3.4K | - |
| May 1, 2026 | Jeffrey Wayne Sheets
Director
|
Grant | 3.4K | - |
| Apr 29, 2026 | Peuch Olivier Le
Chief Executive Officer
|
Sell | 25.0K | $1.4M |
| Mar 26, 2026 | La Chevardiere Patrick De
Director
|
Sell | 4.0K | $208.1K |
| Mar 25, 2026 | Peuch Olivier Le
Chief Executive Officer
|
Sell | 25.0K | $1.3M |
| Mar 13, 2026 | Stephane Biguet
Chief Financial Officer
|
Grant | 3.5K | - |
| Mar 13, 2026 | Steve Matthew Gassen
Officer
|
Grant | 1.2K | - |
| Mar 13, 2026 | Howard Guild
Officer
|
Grant | 801 | - |
| Mar 13, 2026 | Peuch Olivier Le
Chief Executive Officer
|
Grant | 12.0K | - |
| Mar 13, 2026 | Abdellah Merad
Officer
|
Grant | 3.5K | - |
| Mar 13, 2026 | Demosthenis Pafitis
Chief Technology Officer
|
Grant | 2.5K | - |
| Mar 13, 2026 | Dianne B Ralston
Officer
|
Grant | 3.2K | - |
| Feb 25, 2026 | Peuch Olivier Le
Chief Executive Officer
|
Sell | 25.0K | $1.3M |
| Jan 28, 2026 | Peuch Olivier Le
Chief Executive Officer
|
Sell | 25.0K | $1.3M |
| Jan 26, 2026 | Stephane Biguet
Chief Financial Officer
|
Sell | 61.0K | $3.0M |
| Jan 26, 2026 | Abdellah Merad
Officer
|
Sell | 60.0K | $3.0M |
| Jan 26, 2026 | Dianne B Ralston
Officer
|
Sell | 18.6K | $921.5K |
| Jan 26, 2026 | Howard Guild
Officer
|
Sell | 13.3K | $659.4K |
| Jan 26, 2026 | La Chevardiere Patrick De
Director
|
Sell | 4.0K | $201.2K |
| Jan 23, 2026 | Stephane Biguet
Chief Financial Officer
|
Grant | 51.9K | - |
| Jan 23, 2026 | Steve Matthew Gassen
Officer
|
Grant | 17.8K | - |
| Jan 23, 2026 | Howard Guild
Officer
|
Grant | 11.9K | - |
| Jan 23, 2026 | Peuch Olivier Le
Chief Executive Officer
|
Grant | 177.9K | - |
| Jan 23, 2026 | Abdellah Merad
Officer
|
Grant | 51.9K | - |
| Jan 23, 2026 | Demosthenis Pafitis
Chief Technology Officer
|
Grant | 37.1K | - |
| Jan 23, 2026 | Dianne B Ralston
Officer
|
Grant | 47.4K | - |
| Jan 16, 2026 | Stephane Biguet
Chief Financial Officer
|
Grant | 15.8K | - |
| Jan 16, 2026 | Steve Matthew Gassen
Officer
|
Grant | 5.4K | - |
| Jan 16, 2026 | Howard Guild
Officer
|
Grant | 3.6K | - |
| Jan 16, 2026 | Peuch Olivier Le
Chief Executive Officer
|
Grant | 54.1K | - |
| Jan 16, 2026 | Abdellah Merad
Officer
|
Grant | 15.8K | - |
| Jan 16, 2026 | Demosthenis Pafitis
Chief Technology Officer
|
Grant | 11.3K | - |
| Jan 16, 2026 | Dianne B Ralston
Officer
|
Grant | 14.4K | - |
| Nov 26, 2025 | Peter John Coleman
Director
|
Sell | 5.5K | $197.0K |
| Nov 13, 2025 | Stephane Biguet
Chief Financial Officer
|
Sell | 38.4K | $1.4M |
| Nov 11, 2025 | Abdellah Merad
Officer
|
Sell | 60.0K | $2.3M |
| Sep 12, 2025 | Dianne B Ralston
Officer
|
Sell | 39.7K | $1.4M |
| Jul 18, 2025 | Steve Matthew Gassen
Officer
|
Grant | 12.4K | - |
| Jul 18, 2025 | Rakesh Jaggi
Officer
|
Grant | 4.1K | - |
| Jul 18, 2025 | Ugo Prechner
Officer
|
Grant | 9.3K | - |
| May 22, 2025 | La Chevardiere Patrick De
Director
|
Sell | 5.0K | $167.9K |
| May 1, 2025 | Peter John Coleman
Director
|
Grant | 5.7K | - |
| May 1, 2025 | La Chevardiere Patrick De
Director
|
Grant | 5.7K | - |
| May 1, 2025 | Miguel Matias Galuccio
Director
|
Grant | 5.7K | - |
| May 1, 2025 | James T Hackett
Director
|
Grant | 8.7K | - |
| May 1, 2025 | Samuel Georg Friedrich Leupold
Director
|
Grant | 5.7K | - |
| May 1, 2025 | Hanssen Maria Moraeus
Director
|
Grant | 5.7K | - |
| May 1, 2025 | Vanitha Narayanan
Director
|
Grant | 5.7K | - |
| May 1, 2025 | Jeffrey Wayne Sheets
Director
|
Grant | 5.7K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.